Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > Rats fleeing the sinking ship
View:
Post by kuatolives on May 24, 2017 3:56pm

Rats fleeing the sinking ship

https://www.conferencecalltranscripts.org/4/summary2/?id=3822812
Comment by biggerr on May 25, 2017 10:03am
just one rat
Comment by GoldenDilemma on May 25, 2017 10:56am
Dumping shares that he bought at $5.86 back in September 2016. Plus runs a hedge fund and surely knows when to buy low and sell high, right? Oh, and one month before Zontivity launch.... but yeah, no big deal ;) 
Comment by biggerr on May 25, 2017 11:59am
if this guy runs a hedge fund he has no business being on the board of ARZ - these hedge fund guys are cold-hearted operators who only think of making money. Maybe he shorted ARZ thinking that his sale will cause the stock to drop, you never know what's behind somebody's actions
Comment by GoldenDilemma on May 25, 2017 11:59am
Spare me the BS. 
Comment by kuatolives on May 25, 2017 7:12pm
Harris has no business being on the board either, given how badly he sold-out his shareholders, yet there he is. We're trying to help you bigerr (and others); take your lumps and get out. The interest on the debt alone will total 25% of the anual gross this year. Yosprala is a flop and they're pinning their hopes on a drug that was already deemed to be a flop once already. Directors are ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities